Letter to the editor, "Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications"

Harmen R. Moes*, Erik Buskens, Teus van Laar

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

1 Citation (Scopus)
10 Downloads (Pure)


The MANAGE-PD tool may help general neurologists in deciding whether a patient with advanced Parkinson's disease should be referred for an advanced therapy. Although the development and clinical validation of MANAGE-PD would appear to serve an important need, we urge the reader to be aware of several methodological concerns.

Original languageEnglish
Pages (from-to)99-100
Number of pages2
JournalParkinsonism & Related Disorders
Early online date25-Mar-2022
Publication statusPublished - Apr-2022


  • Parkinson's disease
  • Advanced therapy
  • Patient identification
  • Decision Support Techniques
  • Levodopa-carbidopa intestinal gel (LCIG)
  • Deep brain stimulation (DBS)
  • Continuous subcutaneous apomorphine infu-sion (CSAI)

Cite this